SCHEMBL27101539

SCHEMBL27101539

OB(O)c1ccc(N(c2ccccc2)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ LMNA P02545 1/20 0.40
▸ AHR P35869 2/20 0.39
▸ BCAT1 P54687 1/20 0.38
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ CA5A P35218 1/20 0.37
▸ CA7 P43166 1/20 0.37
▸ ENPP2 Q13822 1/20 0.37
▸ CA14 Q9ULX7 1/20 0.37
▸ CA5B Q9Y2D0 1/20 0.37
▸ CA1 P00915 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26572527 0.91 AHR (0.42) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL15730657 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL26154382 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL14295296 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL10042889 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL23308823 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL12936127 0.89 MAPT (0.52) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL26815524 0.88 AHR (0.45) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL19801857 0.86 MAPT (0.49) MAPTKDM4EHPGDNPC1MEN1
SCHEMBL17369967 0.86 MAPT (0.49) MAPTKDM4EHPGDNPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-02-29 — — US disclosed
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2024-02-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240074306-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, MANUFACTURING METHOD THEREFOR, AND COMPOSITION FOR ORGANIC LAYER CYP1B1, NOTUM, WEE1 MAPT 1259/4885KDM4E 2624/4885HPGD 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback